Skip to main content
Full access
Letter to the Editor
Published Online: 1 October 2000

Measuring Dopamine D2 Receptors

To the Editor: Nora D. Volkow, M.D., et al. (1) used [11C]raclopride and positron emission tomography (PET) to show differences in the striatal dopamine system between subjects who rated the effects of intravenous methylphenidate as pleasant and subjects who rated the effects as unpleasant. They concluded that the subjects in the first group had fewer striatal dopamine 2 (D2) receptors and that this may be a predisposing factor to drug addiction. However, the method they used does not measure D2 receptor density.
It has been shown by their group (2) and others (35) that the binding of [11C]raclopride depends on the level of endogenous dopamine present at the time of the scan. They incorrectly stated that the [11C]raclopride distribution volume (sometimes also referred to as binding potential) equals Bmax/KD, the ratio of total D2 receptor density to the dissociation constant of radiotracer and receptor. In fact, the distribution volume, as they calculated it, is more properly expressed as
where Nf   is the concentration of free dopamine and Kd/D is the affinity of dopamine for the D2 receptor (6).
This does not invalidate their result; however, the conclusion can only be that they showed a difference in the striatal dopamine system between the two groups of individuals, rather than a difference in dopamine receptor density. The former is a somewhat weak conclusion, as it does not necessarily imply an intrinsic or inherited difference in dopamine receptor numbers.
The brain is never in a “baseline” state, and a PET scan is a measure of the neurometabolic response to the experience of undergoing a PET scan, which may include varying degrees of anxiety and discomfort in different individuals. For example, one could imagine that subjects who are more anxious than others have a greater release of dopamine during PET scanning, which would affect the [11C]raclopride distribution volume. In short, it is not possible to measure D2 receptor density with [11C]raclopride with a single PET scan, although it can be done by using two scans with injections of radiotracer at different specific activity levels (7). Therefore, the theory that D2 receptor density is related to the risk of addiction is not supported by this PET study.

References

1.
Volkow ND, Wang G-J, Fowler JS, Logan J, Gatley SJ, Gifford A, Hitzemann R, Ding YS, Pappas N: Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 levels. Am J Psychiatry 1999; 156:1440–1443
2.
Smith GS, Dewey SL, Brodie JD, Logan J, Vitkun SA, Simkowitz P, Schloesser R, Alexoff DA, Hurley A, Cooper T, Volkow ND: Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects. Am J Psychiatry 1997; 154:490–496
3.
Carson RE, Breier A, de Bartolomeis A, Saunders RC, Su TP, Schmall B, Der MG, Pickar D, Eckelman WC: Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. J Cereb Blood Flow Metab 1997; 17:437–447
4.
Koepp MJ, Gunn RN, Lawrence AD, Cunningham VJ, Dagher A, Jones T, Brooks DJ, Bench CJ, Grasby PM: Evidence for striatal dopamine release during a video game. Nature 1998; 393:266–268
5.
Dewey SL, Smith GS, Logan J, Brodie JD, Fowler JS, Wolf AP: Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 1993; 13:350–356
6.
Endres CJ, Carson RE: Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands. J Cereb Blood Flow Metab 1998; 18:1196–1210
7.
Farde L, Eriksson L, Blomquist G, Halldin C: Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET: a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 1989; 9:696–708

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1708 - 1709
PubMed: 11007741

History

Published online: 1 October 2000
Published in print: October 2000

Authors

Affiliations

ALAIN DAGHER, M.D.
Montreal, Que., Canada

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share